The Study
Microglia as a key mediator in rosuvastatin-associated cognitive impairment.
This study looked at brain immune cells in a dish and used computer models to see how they react to a cholesterol drug called rosuvastatin. It found the drug might change how these cells work, which could be linked to memory problems — but we can't say for sure it causes them in real people.
Analysis score
Maximum 0 for a computational/algorithm study.
Where the score came from
This study looked at how a common cholesterol drug, rosuvastatin, affects brain cells called microglia that help keep the brain healthy.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 50 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1These changes might help explain why some people taking statins report memory issues, but it doesn't prove the drug causes it.
- 2Rosuvastatin changed how microglia work in lab tests, including how they move, clean up waste, and respond to inflammation.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Neurotoxicology
Year
2026
Authors
Xianzheng Sang, Yichao Ye, Chengzi Yang, X. Hou, Yangu Guo, Hantong Shi, Chunhui Wang, Wen Chen, Danfeng Zhang, Lijun Hou
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.